Invesaro

Stocks Health care NXL

NASDAQ · Health care

Nexalin Technology, Inc. (NXL)

Nexalin Technology, Inc. brought in $217.2K of revenue over the twelve months to June 30, 2026, up 24.2% from a year earlier. It posted a net loss of $9M. At June 30, 2026 it held $1M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 12, 2026.

Price
$4.39
+0.82% on the day · September 25, 2026
52-week range $4.00 to $60.00
Market cap
$96.7M
Revenue (last 12 months)
$217.2K
+24.2% year on year
Net margin
-4,139.4%

What Nexalin Technology, Inc. does

Nexalin Technology, Inc. is registered with the SEC under industry code SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Its shares trade on NASDAQ under the ticker NXL.

Revenue and profit by year

Revenue
FY22: $144.1K $144.1K FY22FY22: $1.3M $1.3M FY22FY23: $110.7K $110.7K FY23FY24: $168.7K $168.7K FY24FY25: $301.6K $301.6K FY25
Net income
FY22: -$6.1M -$6.1M FY22FY22: -$1.7M -$1.7M FY22FY23: -$4.6M -$4.6M FY23FY24: -$7.6M -$7.6M FY24FY25: -$8.2M -$8.2M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$301.6K-$8.4M-$8.2M-$0.50n/a
2024$168.7K-$7.8M-$7.6M-$0.83n/a
2023$110.7K-$5.7M-$4.6M-$0.63n/a
2022$1.3M-$1.8M-$1.7M-$0.30n/a
2022$144.1K-$6M-$6.1Mn/an/a
Next report expected around November 13, 2026.

Estimated from its filing rhythm: 52 weeks after its report of November 14, 2025. Not a date the company has announced. See the report calendar

Where NXL ranks in Health care

Revenue$301.6K
#604 of 646 in Health care · Bottom 7%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Nexalin Technology, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 22, 2026
  2. September 3, 2026
  3. September 3, 2026
  4. September 2, 2026
  5. August 27, 2026
  6. August 27, 2026
  7. August 21, 2026
  8. August 20, 2026
  9. August 20, 2026
  10. August 17, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on December 23, 2025. Insider transactions on SEC

Who owns NXL

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Alumni Capital LP13G, passive with 2 related filers 9.99% 2,493,075 August 27, 2026
Greenlight Ventures, LLC13D, may seek influence 5.6% 1,385,246 September 3, 2026

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

We have not read this company's Form 4 filings yet.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about NXL

What does Nexalin Technology, Inc. do?

Nexalin Technology, Inc. is registered with the SEC under industry code SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Its shares trade on NASDAQ under the ticker NXL.

Is Nexalin Technology, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $9M on revenue of $217.2K.

How much revenue does Nexalin Technology, Inc. make?

Over the twelve months to June 30, 2026 Nexalin Technology, Inc. reported revenue of $217.2K. That is 24.2% more than a year earlier.

When did Nexalin Technology, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 12, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the employee stock plan registration from September 22, 2026.

Similar companies

Compare NXL with

Compare NXL with any company

Follow NXL

Get an email when Nexalin Technology, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow NXL: get an email when it files

Where the numbers come from

Financial figures are the values Nexalin Technology, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.